In this regard, it is worthwhile mentioning that plasma levels of PTX3 were increased at the onset of GVHD and were predictive of disease outcome (43), although the potential contribution of genetic variation in PTX3 to the risk and progression of GVHD remains to be assessed. The gene discussed is PTX3; the disease is graft versus host disease.